Value Hive Podcast cover image

Shrubbery Capital Pt. 2: Process, Simplicity, & TikTok Investing

Value Hive Podcast

00:00

Regeneron and Aylia - What's the Difference?

I was long regenerant at some point, which I think is a fantastic company. Their pharma business was a weak spot for them before Monsanto. They have a drug called Asudexium, which is the most promising drug in their pipeline. The companies in this is going to be buyer, Bristol Myers, Johnson & Johnson. And if they had been ex-litigation, this would have been a very valuable company.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app